Close
CDMO Safety Testing 2026
Novotech

IT & Data Management

Fluorescence Guided Surgery For Bone Cancer Patients- A Boon

Consultant Orthopaedic Oncologist and Honorary Senior Lecturer at the Newcastle University, Dr. Kenneth Rankin has decided to reunite with his fellow specialists across the Netherlands, UK, Japan, Canada, and USA to push new surgical treatment technologies in cases of...

DNA Medication Pass Is The Way Forward To Dip Side Effects

The Lancet study is the first to showcase the practical use of prescription medications based on an individual's genetic information. The one-size-fits-all approach to pharmaceutical prescription is out of date. Patients may react differently to a specific medicine due to...

The ePI Deconstructed – A New Frontier in Patient Communication

Pharma manufacturers face several challenges when it comes to labels, both in terms of design and production. As the label size tends to increase every year, adding clarity, consistency, and appeal is becoming increasingly difficult. Pharmaceutical manufacturers also face...

Cancer Mutation Analysis Through AI- A Strong Step Forward

When single-cell data is combined with a self-learning algorithm, it is a revelation as to how structural changes can go on to trigger cancer. This new methodology can indeed pave the road for cancer treatments that are personalised in...

Aortic Stability Evaluation To Find Patients At High Risk

According to a recent study conducted in collaboration by the University of Eastern Finland and Kuopio University Hospital, patients with ascending aortic dilatation are more likely to experience pathological changes in the aortic wall when wall shear stress values...

Addressing Diseases Through Technology – A New Revolution

To grasp the intricate pathology of many diseases today, scientists and researchers have achieved amazing advances in basic science. The ability of the human mind to think critically and come up with answers is unmatched, and some of that...

5 Challenges That Will Affect Developing Biotech In 2023

Drugmakers' initial stock offerings, which had been a dependable tradition for years, mostly stopped in 2022. Fewer than two dozen biotech businesses priced initial public offerings (IPOs) last year, a 79% decrease from the total of the prior year...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป